Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus

Abdul Rahman Azizogli, Michael R. Vitti, Richa Mishra, Laura Osorno, Corey Heffernan, Vivek A. Kumar

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds